Supplementary Figure S2. Fractionation of trypsin digests of [ 3 H]TFD-etomidate labeled β subunit by Tricine-SDS PAGE (A and B) and rpHPLC purification (C and D) of the fragments beginning at βMet-249 (βM2). The β subunits isolated from the [
3 H]TFD-etomidate nAChR photolabelings described in Supp. Fig. S1 in the absence (open bars, ) or the presence of tetracaine (gray bars, ) or Carb (solid bars, )) were digested with trypsin (~16 h), and the digests were fractionated on small pore (16.5%T, 6%C) Tricine SDS-PAGE gels as described under "Materials and Methods". After electrophoresis, the Tricine gels were cut into equal slices and the polypeptides were recovered from gel slices by passive elution in 12 mls of elution buffer. A and B, the 3 H distribution, determined by scintillation counting of 10% of the eluates. Eluates from gel slices 6-9 were each concentrated to less than 500 µL and fractionated by rpHPLC. Representative rpHPLC fractionation profiles for gel slice #7 from A (-/+ tetracaine) and gel slice #6 from B (-/+ Carb), which run with apparent molecular mass of 8-10 kDa, are shown in C and D, respectively.
3 H recovery was >95%. HPLC fractions 31-32, containing the fragment beginning at βMet-249, were pooled for amino acid sequence analysis (shown in Figures 5B and 7B, βMet-249, ~40 pmol and 18 pmol, respectively). Additional fractions sequenced from A (−/+ tetracaine): gel slice #6, rpHPLC fractions 29-32, which contained the fragment beginning at βMet-249 (7 pmol) contaminated with trypsin peptides and a 3 H release profile similar to that in Figure 5B ; gel slice #8, rpHPLC fractions 28-30, which contained the fragment beginning at βAsp-425 (30 pmol) and a 3 H release at cycle 15 indicating labeling of βTyr-441 (-/+ tetracaine, 14/12 cpm/pmol). Sequence analysis of rpHPLC fractions 28-30 from gel slice #9 from B (−/+ Carb) is described in Figure 8B . , were digested with Endo-Lys C (0.5 units, 2 weeks), and the digests were fractionated by Tricine-SDS PAGE. The 3 H distributions from the gels, which were processed as described in the legend of Supplementary Figure S2 , are shown in A and B, and rpHPLC fractionation profiles for gel slice #5 from A and B, which run with apparent molecular mass of ~14 kDa, are shown in C and D, respectively. For nAChR photolabeled in the absence and presence of tetracaine (A, C), sequence analysis of rpHPLC fractions 27-30 is shown in Figure 5C . Sequence analysis of fractions 23-25 revealed the presence of fragment beginning at δPhe-206 (25 pmol), with 3 H releases at cycles 27 and 31 of Edman degradation indicating labeling (<1 cpm/pmol) at δPhe-232 and δCys-236 within δM1. Sequence analysis of fractions 28-30 from the rpHPLC fractionation of gel slice #6 revealed the presence at equal levels (19 pmol) of peptides beginning at δMet-257 and δAsn-437, with the 3 H release profile similar to that in Figure 5B . For the nAChR labeled in the absence and presence of Carb (B, D), amino sequence analysis of rpHPLC fractions 27-30 is shown in Figure 7C , while sequence analysis of fractions equivalent to fractions 22-25 from a photolabeling at 0.4 µM [ 3 H]TFD-etomidate are shown in Figure 8C . Sequence analysis of fractions 22-25 from D revealed that EndoLys-C had cleaved at δLys-199 rather than δLys-205, with the amount of the fragment beginning at δAsn-200 (10 pmol) too low to allow successful sequencing for the 37 cycles necessary to reach the photolabeled residues in δM1. 
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